drugset / Trial / NCT00760019

Inflammation and Vascular Function in Atherosclerosis

NCT00760019

Phase 2/3 Completed 58 enrolled Brigham and Women's Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether reducing inflammation in blood vessels with an aspirin-like drug called salsalate will improve blood vessel function.

Timeline

Start
2005-08
Primary completion
2009-10
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salsalate Small molecule 1.5 g Oral

Indications